Skip to main content
. Author manuscript; available in PMC: 2022 Sep 2.
Published in final edited form as: J Virol Methods. 2021 Aug 9;297:114262. doi: 10.1016/j.jviromet.2021.114262

Table 1.

Summary of commercial nucleic acid extraction buffers used in this study.

Extraction Buffer (EB) Kit Vendor Guanidine Thiocyanate content Sample:EB Ratio Additional Components Added Sample/Buffer Incubation Time (Kit)
Viral RNA Buffer Quick-RNA Viral Kit Zymo Research ≤6 M (70 %) 1:3 0.5% β-ME added Not Specified
Binding Buffer High Pure Viral Nucleic Acid Kit Roche Diagnostics None (6 M Guanidine HCl) 1:1 Proteinase K Proteinase K +10 min
MagMAX Lysis/Binding Concentrate MagMAX Pathogen RNA/DNA Kit
MagMAX-96 Viral Isolation RNA Kit
Applied Biosystems 4.65–6.77M (55–80 %) 1:2 None Not Specified
Buffer AVL QIAamp Viral RNA Mini kit Qiagen 4.2–6 M (50–70 %) 1:4 Ethanol added (44 % final) 10 min
UNEX N/A VWR/Microbiologics 4.1 M (48 %) 1:1 Ethanol added (50 % final) 10 min
Trizol LS N/A Invitrogen 1.3–3.4 M (15–40 %) 1:1 None Not Specified